These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34686507)
21. A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer. Jing H; Qu X; Liu L; Xia H Med Sci Monit; 2018 Jun; 24():4317-4323. PubMed ID: 29935018 [TBL] [Abstract][Full Text] [Related]
22. The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer. Jiao Y; Li Y; Jia B; Chen Q; Pan G; Hua F; Liu Y Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31967298 [TBL] [Abstract][Full Text] [Related]
23. SP1-mediated overexpression of lncRNA LINC01234 as a ceRNA facilitates non-small-cell lung cancer progression via regulating OTUB1. Xie JJ; Guo QY; Jin JY; Jin D J Cell Physiol; 2019 Dec; 234(12):22845-22856. PubMed ID: 31106421 [TBL] [Abstract][Full Text] [Related]
24. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer. Fan KJ; Liu Y; Yang B; Tian XD; Li CR; Wang B Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550 [TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer. Luo J; Tang L; Zhang J; Ni J; Zhang HP; Zhang L; Xu JF; Zheng D Tumour Biol; 2014 Nov; 35(11):11541-9. PubMed ID: 25129441 [TBL] [Abstract][Full Text] [Related]
26. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259 [TBL] [Abstract][Full Text] [Related]
27. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Tantai J; Hu D; Yang Y; Geng J Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353 [TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484 [No Abstract] [Full Text] [Related]
29. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
30. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597 [TBL] [Abstract][Full Text] [Related]
31. Long intergenic noncoding RNA LINC00173 as a potential serum biomarker for diagnosis of non-small-cell lung cancer. Yang Q; Kong S; Zheng M; Hong Y; Sun J; Ming X; Gu Y; Shen X; Ju S Cancer Biomark; 2020; 29(4):441-451. PubMed ID: 32623390 [TBL] [Abstract][Full Text] [Related]
32. Serum lncRNA LOXL1-AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer. Liu CN; Zhang HY J Gene Med; 2020 Oct; 22(10):e3233. PubMed ID: 32449981 [TBL] [Abstract][Full Text] [Related]
33. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway. Gao BB; Wang SX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077 [TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression. Qu CH; Sun QY; Zhang FM; Jia YM Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092 [TBL] [Abstract][Full Text] [Related]
35. Long noncoding nature brain-derived neurotrophic factor antisense is associated with poor prognosis and functional regulation in non-small cell lung caner. Shen M; Xu Z; Jiang K; Xu W; Chen Y; Xu Z Tumour Biol; 2017 May; 39(5):1010428317695948. PubMed ID: 28459374 [TBL] [Abstract][Full Text] [Related]
36. LncRNA KCNQ1OT1 is overexpressed in non-small cell lung cancer and its expression level is related to clinicopathology. Zheng L; Zhang FX; Wang LL; Hu HL; Lian YD Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6944-6950. PubMed ID: 31486494 [TBL] [Abstract][Full Text] [Related]
37. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma. Xu R; Feng F; Yu X; Liu Z; Lao L Cell Prolif; 2018 Dec; 51(6):e12515. PubMed ID: 30152090 [TBL] [Abstract][Full Text] [Related]
38. Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer. Chen J; Hu L; Wang J; Zhang F; Chen J; Xu G; Wang Y; Pan Q Pathol Oncol Res; 2017 Apr; 23(2):265-270. PubMed ID: 27411923 [TBL] [Abstract][Full Text] [Related]
39. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer. Wang SY; Li Y; Jiang YS; Li RZ Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091 [TBL] [Abstract][Full Text] [Related]
40. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]